Physician profile
Dilip Kamath
NPI 1023549714
$9,806.51
in general payments reported to CMS, 2019-2025
17 companies · $824 in 2025
The $824 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.63 · 2022: $1,791 · 2023: $6,079 · 2024: $1,083 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,505 · Travel and Lodging: $3,444 · Education: $37.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,505.15 |
| Travel and Lodging | $3,443.54 |
| Education | $37.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,250.72 | 2022-2025 | Proclaim, Eterna, Ionicrf |
| Medtronic, INC. | $2,245.84 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $787.69 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Spr Therapeutics, INC | $443.76 | 2022-2023 | Sprint Pns System |
| Nalu Medical, INC. | $396.84 | 2022-2023 | Nalu Neurostimulation System |
| Nevro Corp. | $146.38 | 2023-2024 | Senza |
| Si-Bone, INC. | $96.95 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.11 | 2024-2025 | Relistor |
| Curonix LLC | $83.85 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Protega Pharmaceutials INC | $53.69 | 2025 | Roxybond |
| Scilex Pharmaceuticals INC. | $43.46 | 2023-2024 | Ztlido |
| Globus Medical, INC. | $39.31 | 2025 | Senza |
| Tersera Therapeutics LLC | $29.63 | 2019 | |
| Saluda Medical Americas, INC. | $26.72 | 2024 | Evoke |
| Averitas Pharma INC. | $23.36 | 2025 | Qutenza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $21.97 | 2025 | |
| Abbvie INC. | $21.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilip Kamath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.